About
Molecular Detection is developing SEPSIS-xxpress, a hospital-based instrument for rapid sepsis diagnosis and pathogen profiling. SEPSIS-xxpress provides doctors with the specific pathogen and antibiotic-resistance profile necessary to treat infection in the critical early hours. The SEPSIS-xxpress system comprises an instrument platform with embedded touchscreen computer and test kits with single-use, disposable cartridges pre-loaded with all needed reagents. Hospital staff cansimply draw a patient's blood sample, insert the vacutainer into a test cartridge, and start the test. The comprehensive diagnosis is then presented on-screen in less than threehours.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary product developed by Molecular Detection?
- Molecular Detection is developing SEPSIS-xxpress, a hospital-based instrument designed for rapid sepsis diagnosis and pathogen profiling.
- What is the core functionality of the SEPSIS-xxpress system?
- The SEPSIS-xxpress system provides doctors with specific pathogen and antibiotic-resistance profiles to treat infections in the critical early hours, delivering a comprehensive diagnosis in less than three hours.
- When was Molecular Detection founded?
- Molecular Detection was founded in February 2007.
- What is the current operational status of Molecular Detection?
- According to startupim data, Molecular Detection has been inactive since October 2016.
- Where is Molecular Detection headquartered?
- Molecular Detection is headquartered in Jerusalem, Israel, at E.S. Artom Street 10.
- What is the employee count for Molecular Detection?
- Molecular Detection has an employee count of 31, falling within the 11-50 employee bucket.
- What is the total amount of funding raised by Molecular Detection?
- Molecular Detection has raised a total of $0 USD.
- What are the primary geographic markets targeted by Molecular Detection?
- Molecular Detection targets the geographic markets of China and the United States.
- In which sector does Molecular Detection primarily operate?
- Molecular Detection primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Diagnostics Devices.